Related Experiment Video
Updated: Jan 25, 2026
The Organotypic Hippocampal Slice Culture Model for Examining Neuronal Injury
Published on: October 28, 2010
Dexmedetomidine reduces hippocampal microglia inflammatory response induced by surgical injury through inhibiting
Ji Peng1, Peng Zhang1, Han Zheng1
1Department of Anesthesiology, Daping Hospital, Army Medical University, Chongqing 400042, China.
Purpose:
To investigate whether dexmedetomidine (Dex) can reduce the production of inflammatory factor IL-1β by inhibiting the activation of NLRP3 inflammasome in hippocampal microglia, thereby alleviating the inflammatory response of the central nervous system induced by surgical injury.
Methods:
Exploratory laparotomy was used in experimental models in this study. Totally 48 Sprague Dawley male rats were randomly divided into 4 groups (n = 12 for each), respectively sham control (group A), laparotomy only (group B); and Dex treatment with different doses of 5 μg/kg (group D1) or 10 μg/kg (group D2). Rats in groups D1 and D2 were intraperitoneally injected with corresponding doses of Dex every 6 h. The rats were sacrificed 12 h after operation; the hippocampus tissues were isolated, and frozen sections were made. The microglia activation was estimated by immunohistochemistry. The protein expression of NLRP3, caspase-1, ASC and IL-1β were detected by immunoblotting. All data were presented as mean ± standard deviation, and independent sample t test was used to analyze the statistical difference between groups.
Results:
The activated microglia in the hippocampus of the rats significantly increased after laparotomy (group B vs. sham control, p < 0.01). After Dex treatment, the number was decreased in a dose-dependent way (group D1 vs. D2, p < 0.05), however the activated microglia in both groups were still higher than that of sham controls (both p < 0.05). Further Western blot analysis showed that the protein expression levels of NLRP3, caspase-1, ASC and downstream cytokine IL-1β in the hippocampus from the laparotomy group were significantly higher than those of the sham control group (all p < 0.01). The elevated expression of these proteins was relieved after Dex treatment, also in a dose-dependent way (D2 vs. D1 group, p < 0.05).
Conclusion:
Dex can inhibit the activation of microglia and NLRP3 inflammasome in the hippocampus of rats after operation, and the synthesis and secretion of IL-1β are also reduced in a dose-dependent manner by using Dex. Hence, Dex can alleviate inflammation activation on the central nervous system induced by surgical injury.
Insights
Dexmedetomidine (Dex) reduces central nervous system inflammation after surgery by inhibiting microglia activation and NLRP3 inflammasome in rats. This study shows Dex effectively lowers IL-1β production, alleviating post-operative neuroinflammation.
Area of Science:
- Neuroscience
- Pharmacology
- Immunology
Background:
- Surgical injury can trigger central nervous system inflammation.
- Microglia activation and NLRP3 inflammasome pathway are key mediators of neuroinflammation.
- Interleukin-1 beta (IL-1β) is a critical pro-inflammatory cytokine involved in this process.
Purpose of the Study:
- To determine if dexmedetomidine (Dex) inhibits NLRP3 inflammasome activation in hippocampal microglia.
- To investigate Dex's effect on IL-1β production following surgical injury.
- To assess Dex's potential to alleviate neuroinflammation induced by surgery.
Main Methods:
- Adult male Sprague Dawley rats underwent exploratory laparotomy.
- Rats were divided into sham control, laparotomy only, and two Dex treatment groups (5 μg/kg and 10 μg/kg).
- Hippocampal microglia activation, NLRP3, caspase-1, ASC, and IL-1β protein levels were analyzed via immunohistochemistry and Western blotting.
Main Results:
- Laparotomy significantly increased microglia activation and NLRP3 inflammasome component expression in the hippocampus.
- Dex treatment dose-dependently reduced microglia activation and NLRP3 inflammasome markers.
- Dex administration significantly decreased IL-1β levels in a dose-dependent manner.
Conclusions:
- Dexmedetomidine effectively inhibits microglia activation and NLRP3 inflammasome pathway activation in the hippocampus post-surgery.
- Dex reduces the synthesis and secretion of IL-1β in a dose-dependent manner.
- Dex demonstrates potential as a therapeutic agent to mitigate central nervous system inflammation resulting from surgical injury.
Related Concept Videos
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:24Inflammatory Response II: Inflammatory Exudate and Tissue Repair
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Response I: Vascular and Cellular
00:46Feedback Inhibition
01:18Reducing Line Loss
With a step-up transformer at the source, the voltage is increased, thereby reducing the current in the transmission lines since power loss in...